Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-25

Clinical Trial Update: Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine [Phase 4]

View source ↗

Summary

Phase IV study evaluating interchangeability of a liquid pentavalent combination vaccine for diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentavalent liquid combination vaccine (pentavalent vaccine)

Snippet

Sponsor: Shantha Biotechnics Limited | Conditions: Diphtheria, Tetanus | Phase 4 | Status: COMPLETED